{"transactions":[{"id":699536,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2026-08-03T13:28:26.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":84,"price":297.78,"value":25013.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Company's Directors' Deferred Compensation Sub-Plan, the reporting person elected to defer his quarterly cash retainer payment into Stock Equivalent Units. At the time\nof distribution, stock equivalent units convert to common shares on a one-for-one basis"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 16 Stock Equivalent Units and/or Restricted Share Units accrued from dividend payments pursuant to the Company's Stock Incentive and Award Plan."}],"balance_after":5902,"source":{"system":"sec-edgar","filing":"0001403373-26-000007","document":"wk-form4_1785763704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000140337326000007/wk-form4_1785763704.xml","form_type":"4"}},{"id":760043,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-28T22:20:20.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":46293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders."}],"balance_after":205478,"source":{"system":"sec-edgar","filing":"0001403373-26-000005","document":"wk-form4_1780006817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000140337326000005/wk-form4_1780006817.xml","form_type":"4"}},{"id":794960,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2026-05-04T13:13:18.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":87,"price":288.45,"value":25095.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Company's Directors' Deferred Compensation Sub-Plan, the reporting person elected to defer his quarterly cash retainer payment into Stock Equivalent Units.   At the time of distribution, stock equivalent units convert to common shares on a one-for-one basis"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 18 Stock Equivalent Units and/or Restricted Share Units accrued from dividend payments pursuant to the Company's Stock Incentive and Award Plan."}],"balance_after":5802,"source":{"system":"sec-edgar","filing":"0001403373-26-000004","document":"wk-form4_1777900395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000140337326000004/wk-form4_1777900395.xml","form_type":"4"}},{"id":924035,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2026-02-03T15:05:33.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":91,"price":274.53,"value":24982.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of the Company's Directors' Deferred Compensation Sub-Plan, the reporting person elected to defer his quarterly cash retainer payment into Stock Equivalent Units. At the time\nof distribution, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 19 Stock Equivalent Units and/or Restricted Share Units accrued from dividend payments pursuant to the Company's Stock Incentive and Award Plan."}],"balance_after":5697,"source":{"system":"sec-edgar","filing":"0001403373-26-000002","document":"wk-form4_1770131130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000140337326000002/wk-form4_1770131130.xml","form_type":"4"}},{"id":932118,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-01-23T21:49:37.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 21, 2026, and will vest on January 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":94.15,"expiration_date":"2036-01-21","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-021195","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000119312526021195/ownership.xml","form_type":"4"}},{"id":1010347,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2025-11-03T18:38:58.000Z","date":"2025-11-01","kind":"grant","planned":false,"acquired":true,"shares":822,"price":231.95,"value":190662.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2025, the Company awarded 822 Restricted Share Units an as annual grant to non-employee directors. The units vest in their entirety on October 31, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 71 Stock Equivalent Units and/or Restricted Share Units accrued from dividend payments pursuant to the Company's Stock Incentive and Award Plan."}],"balance_after":5587,"source":{"system":"sec-edgar","filing":"0001403373-25-000007","document":"wk-form4_1762195135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000140337325000007/wk-form4_1762195135.xml","form_type":"4"}},{"id":1106137,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-18T22:23:59.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":89139,"price":2.16,"value":192540.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on June 16, 2025, which vest in full upon the earlier of one year from the date of grant or the date of the 2026 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders."}],"balance_after":159185,"source":{"system":"sec-edgar","filing":"0001823239-25-000080","document":"wk-form4_1750285433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000182323925000080/wk-form4_1750285433.xml","form_type":"4"}},{"id":1188759,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2025-03-28T23:15:42.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 23, 2025, and will vest on January 1, 2026."}],"balance_after":15000,"derivative":{"exercise_price":92.42,"expiration_date":"2035-01-23","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-047054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000095017025047054/ownership.xml","form_type":"4"}},{"id":1365012,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-11-14T21:32:08.000Z","date":"2024-11-12","kind":"purchase","planned":false,"acquired":true,"shares":17500,"price":5.75,"value":100625.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.72 to $5.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":70046,"source":{"system":"sec-edgar","filing":"0001823239-24-000120","document":"wk-form4_1731619922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000182323924000120/wk-form4_1731619922.xml","form_type":"4"}},{"id":1377876,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2024-11-04T19:31:57.000Z","date":"2024-11-01","kind":"grant","planned":false,"acquired":true,"shares":747,"price":249.03,"value":186025.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 1, 2024, the Company awarded 747 Restricted Share Units an as annual grant to non-employee directors. The units vest in their entirety on October 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 36 Stock Equivalent Units accrued from dividend payments through participation in the Company's Directors' Deferred Compensation Sub-Plan; 9 Restricted Share Units accrued from dividend payments pursuant to the Company's Stock Incentive and Award Plan; and the addition of 5 shares due to an inadvertent rounding error on fractional shares when calculating prior dividend payments.."}],"balance_after":4694,"source":{"system":"sec-edgar","filing":"0000072331-24-000119","document":"wk-form4_1730748710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233124000119/wk-form4_1730748710.xml","form_type":"4"}},{"id":1501800,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-24T21:57:37.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":20645,"price":10.78,"value":222553.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders."}],"balance_after":52546,"source":{"system":"sec-edgar","filing":"0001823239-24-000073","document":"wk-form4_1716587848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000182323924000073/wk-form4_1716587848.xml","form_type":"4"}},{"id":1666417,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-01-30T21:46:32.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2024, and will vest on January 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":53.75,"expiration_date":"2034-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-008908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000095017024008908/ownership.xml","form_type":"4"}},{"id":1752213,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2023-11-02T20:33:41.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":749,"price":211.52,"value":158428.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On November 1, 2023, the Company awarded 749 restricted share units an as annual grant to non-employee directors.  The units vest in their entirety on October 31, 2024."}],"balance_after":3896,"source":{"system":"sec-edgar","filing":"0000072331-23-000183","document":"wk-form4_1698957211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233123000183/wk-form4_1698957211.xml","form_type":"4"}},{"id":1752212,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2023-11-02T20:33:41.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":105,"price":212.59,"value":22321.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan. At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 6  Share Unit Equivalents accrued from dividend payments through participation in the Company's Deferred Compensation Plans and  2 Restricted Share Units accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan."}],"balance_after":3147,"source":{"system":"sec-edgar","filing":"0000072331-23-000183","document":"wk-form4_1698957211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233123000183/wk-form4_1698957211.xml","form_type":"4"}},{"id":1786941,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-09-06T21:25:54.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on September 1, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original Form 4, filed on September 6, 2023, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported an expiration date of September 1, 2024, when in fact such expiration date is September 1, 2033."}],"balance_after":15000,"derivative":{"exercise_price":54.23,"expiration_date":"2033-09-01","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-048453","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000120919123048453/doc4a.xml","form_type":"4/A","original_submission_date":"2023-09-06"}},{"id":1786940,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-06T21:25:54.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":15578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, NuVasive, Inc. (\"NuVasive\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into NuVasive (the \"Merger\"), with NuVasive continuing as a wholly owned subsidiary of the Issuer. At the effective time of the Merger, each NuVasive restricted stock unit award was accelerated, cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Issuer, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of NuVasive common stock underlying such award."}],"balance_after":15578,"source":{"system":"sec-edgar","filing":"0001209191-23-048453","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000120919123048453/doc4a.xml","form_type":"4/A","original_submission_date":"2023-09-06"}},{"id":1786939,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-09-06T20:48:21.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on September 1, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":54.23,"expiration_date":"2024-09-01","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-048412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000120919123048412/doc4.xml","form_type":"4"}},{"id":1786938,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-06T20:48:21.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":15578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, NuVasive, Inc. (\"NuVasive\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into NuVasive (the \"Merger\"), with NuVasive continuing as a wholly owned subsidiary of the Issuer. At the effective time of the Merger, each NuVasive restricted stock unit award was accelerated, cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Issuer, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of NuVasive common stock underlying such award."}],"balance_after":15578,"source":{"system":"sec-edgar","filing":"0001209191-23-048412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000120919123048412/doc4.xml","form_type":"4"}},{"id":1789618,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1789617,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1789616,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1789615,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3095},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1789614,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2577},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1789613,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1789612,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-05T16:40:45.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":563},"source":{"system":"sec-edgar","filing":"0001209191-23-048179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048179/doc4.xml","form_type":"4"}},{"id":1820087,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2023-08-01T17:44:03.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":89,"price":251.61,"value":22393.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan. At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 6 shares accrued from dividend payments through participation in the Company's Deferred Compensation Plans and 2 shares accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan."}],"balance_after":3034,"source":{"system":"sec-edgar","filing":"0000072331-23-000134","document":"wk-form4_1690911834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233123000134/wk-form4_1690911834.xml","form_type":"4"}},{"id":1824753,"issuer":{"id":4291,"kind":"organization","name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","symbol":"MRVI"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-21T20:25:44.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":31901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of July 20, 2024, July 20, 2025, and July 20, 2026, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."}],"balance_after":31901,"source":{"system":"sec-edgar","filing":"0001823239-23-000075","document":"wf-form4_168997112890875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403373/000182323923000075/wf-form4_168997112890875.xml","form_type":"4"}},{"id":1859237,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2023-06-12T17:44:37.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."}],"balance_after":4816,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-036442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123036442/doc4.xml","form_type":"4"}},{"id":1909637,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2023-05-02T20:24:35.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":104,"price":216.31,"value":22496.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan. At the time of distribution, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 4 shares accrued from dividend payments through participation in the Company's Deferred Compensation Plans and 11 shares accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan."}],"balance_after":2937,"source":{"system":"sec-edgar","filing":"0000072331-23-000091","document":"wf-form4_168305906048354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233123000091/wf-form4_168305906048354.xml","form_type":"4"}},{"id":2037974,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2023-02-02T19:46:07.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":92,"price":243.3,"value":22383.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan. At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."}],"balance_after":2818,"source":{"system":"sec-edgar","filing":"0000072331-23-000029","document":"wf-form4_167536715377176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233123000029/wf-form4_167536715377176.xml","form_type":"4"}},{"id":2128100,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2022-11-02T19:11:55.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":730,"price":225.93,"value":164928.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On November 1, 2022, the Company awarded 730 restricted stock units an as annual grant to non-employee directors, valued at the fourth quarter average stock price of $225.93 per share.  Such shares vest on October 31, 2023 unless, with certain exceptions, the reporting person ceases to be a director prior to the vesting date."}],"balance_after":2726,"source":{"system":"sec-edgar","filing":"0000072331-22-000112","document":"wf-form4_166741629654448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233122000112/wf-form4_166741629654448.xml","form_type":"4"}},{"id":2128099,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NDSN","published_at":"2022-11-02T19:11:55.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":100,"price":225,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan. At the time of distribution, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 3 shares accrued from dividend payments through participation in the Company's Deferred Compensation Plans and 2 shares accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan."}],"balance_after":1996,"source":{"system":"sec-edgar","filing":"0000072331-22-000112","document":"wf-form4_166741629654448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000007233122000112/wf-form4_166741629654448.xml","form_type":"4"}},{"id":2198661,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T19:39:01.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":97,"price":230.99,"value":22406.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The total holdings include 2 shares accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan and 2 shares accrued from dividend payments through participation in the Company's Amended and Restated 2005 Deferred Compensation Plan."}],"balance_after":1891,"source":{"system":"sec-edgar","filing":"0001209191-22-043832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919122043832/doc4.xml","form_type":"4"}},{"id":2272331,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-05-13T17:46:14.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3788,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-22-028933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122028933/doc4.xml","form_type":"4"}},{"id":2287336,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T17:50:47.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":104,"price":215.69,"value":22431.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 4 shares accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan and 4 shares accrued from dividend payments through participation in the Company's Amended and Restated 2005 Deferred Compensation Plan."}],"balance_after":1790,"source":{"system":"sec-edgar","filing":"0001209191-22-026369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919122026369/doc4.xml","form_type":"4"}},{"id":2420528,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T15:27:20.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":96,"price":232.54,"value":22323.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."}],"balance_after":1678,"source":{"system":"sec-edgar","filing":"0001209191-22-005797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919122005797/doc4.xml","form_type":"4"}},{"id":2530129,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T20:28:20.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":608,"price":238.43,"value":144965.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On November 1, 2021, the Company awarded 608 restricted stock units as an annual grant to non-employee directors, valued at the fourth quarter average stock price of $238.43 per share. Such shares vest on October 31, 2022 unless, with certain exceptions, the reporting person ceases to be a director prior to the vesting date."}],"balance_after":1582,"source":{"system":"sec-edgar","filing":"0001209191-21-062406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919121062406/doc4.xml","form_type":"4"}},{"id":2530128,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T20:28:20.000Z","date":"2021-10-29","kind":"grant","acquired":true,"shares":79,"price":254.21,"value":20082.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distribution, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 4 shares accrued from dividend payments through participation in the Company's Amended and Restated 2005 Deferred Compensation Plan."}],"balance_after":974,"source":{"system":"sec-edgar","filing":"0001209191-21-062406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919121062406/doc4.xml","form_type":"4"}},{"id":2619312,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T19:40:29.000Z","date":"2021-07-30","kind":"grant","acquired":true,"shares":88,"price":226.13,"value":19899.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."}],"balance_after":892,"source":{"system":"sec-edgar","filing":"0001209191-21-049246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919121049246/doc4.xml","form_type":"4"}},{"id":2703555,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2021-05-20T17:45:41.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2702,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-21-034538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121034538/doc4.xml","form_type":"4"}},{"id":2731998,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-04T12:36:39.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":94,"price":211.41,"value":19872.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distributions, stock equivalent units convert to common shares on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings include 2 shares accrued from dividend payments through participation in the Company's Dividend Reinvestment Plan and 1 share accrued from dividend payments through participation in the Company's Amended and Restated 2005 Deferred Compensation Plan."}],"balance_after":804,"source":{"system":"sec-edgar","filing":"0001209191-21-029661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919121029661/doc4.xml","form_type":"4"}},{"id":2887788,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-02T20:31:52.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":85,"price":178.99,"value":15214.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock Equivalent Units accrued through Nordson's Directors' Deferred Compensation Plan.  At the time of distribution, stock equivalent units convert to common shares on a one-for-one basis."}],"balance_after":707,"source":{"system":"sec-edgar","filing":"0001209191-21-006704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919121006704/doc4.xml","form_type":"4"}},{"id":2967160,"issuer":{"id":30,"kind":"organization","name":"NORDSON CORP","symbol":"NDSN"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-25T22:06:04.000Z","date":"2020-11-23","kind":"grant","acquired":true,"shares":622,"price":196.27,"value":122079.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 23, 2020, the Company awarded 622 restricted share units as an annual grant to the non-employee director, valued at the fourth quarter average stock price of $196.27 per share. Such share units vest on October 31, 2021 unless, with certain exceptions, the reporting person ceases to be a director prior to the vesting date."}],"balance_after":622,"source":{"system":"sec-edgar","filing":"0001209191-20-060545","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72331/000120919120060545/doc4.xml","form_type":"4"}},{"id":3130880,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2020-05-29T17:44:46.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":3095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2021 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2021 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3095,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3095},"source":{"system":"sec-edgar","filing":"0001209191-20-032996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919120032996/doc4.xml","form_type":"4"}},{"id":3531767,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2019-05-10T17:53:39.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2577,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2577},"source":{"system":"sec-edgar","filing":"0001209191-19-029062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919119029062/doc4.xml","form_type":"4"}},{"id":3944440,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T18:03:20.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2019 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2019 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3230,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001209191-18-028414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028414/doc4.xml","form_type":"4"}},{"id":4027713,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-02-28T18:08:12.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on May 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on May 3, 2018."}],"balance_after":563,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":563},"source":{"system":"sec-edgar","filing":"0001209191-18-014645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118014645/doc4.xml","form_type":"4"}},{"id":4116548,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":8658,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":219.555,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":8658},"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116547,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":3768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":168.865,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":3768},"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116546,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":6586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":186.425,"expiration_date":"2025-12-09","underlying":"Common Stock","underlying_shares":6586},"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116545,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":83.82,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"401(k) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Includes 83.82 shares of Bard common stock held through the Bard 401(k) Plan that were disposed of upon the closing of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116544,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":13918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 13,918 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) (\"PLTIP\"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116543,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":13619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Includes 13,619 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program (\"MSPP\").  In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit."}],"balance_after":13918,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116542,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":7758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Includes 7,758 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units."}],"balance_after":27537,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116541,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":687.2316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Includes 687.3216 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration."}],"balance_after":35295,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116540,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":5275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 5,275 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger."}],"balance_after":35982.2316,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4116539,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:32.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":13918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the \"Merger\") of Lambda Corp. (\"Lambda\") with and into C. R. Bard, Inc. (\"Bard\") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company (\"BD\") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the \"Merger Consideration\"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 13,918 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) (\"PLTIP\"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units."}],"balance_after":30707.2316,"source":{"system":"sec-edgar","filing":"0001225208-18-000502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000502/doc4.xml","form_type":"4"}},{"id":4123238,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":false,"shares":2886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Of this option grant 2,886 options vested on December 14, 2017 and the remaining options vest in three annual installments beginning on December 14, 2018."}],"balance_after":8658,"derivative":{"exercise_price":219.555,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":2886},"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123237,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":false,"shares":4161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Options vested on December 11, 2017."}],"balance_after":0,"derivative":{"exercise_price":136.37,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":4161},"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123236,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":false,"shares":3767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Of this option grant 3,767 options vested on December 10, 2017 and the remaining options vest on December 10, 2018."}],"balance_after":3768,"derivative":{"exercise_price":168.865,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":3767},"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123235,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":false,"shares":3293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Of this option grant 3,293 options vested on December 9, 2017 and the remaining options vest in two annual installments beginning on December 9, 2018."}],"balance_after":6586,"derivative":{"exercise_price":186.425,"expiration_date":"2025-12-09","underlying":"Common Stock","underlying_shares":3293},"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123234,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"sale","acquired":false,"shares":13207,"price":333.4341,"value":4403664.1587,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for price increments ranging from $332.96 to $333.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":16789.2316,"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123233,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"sale","acquired":false,"shares":900,"price":334.1189,"value":300707.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for price increments ranging from $333.97 to $334.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":29996.2316,"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123232,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":true,"shares":2886,"price":219.555,"value":633635.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":30896.2316,"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123231,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":true,"shares":3293,"price":186.425,"value":613897.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":28010.2316,"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123230,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":true,"shares":3767,"price":168.865,"value":636114.455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":24717.2316,"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4123229,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-12-22T14:57:38.000Z","date":"2017-12-20","kind":"exercise","acquired":true,"shares":4161,"price":136.37,"value":567435.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 0.0887 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017.  Includes 0.0020 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017."}],"balance_after":20950.2316,"source":{"system":"sec-edgar","filing":"0001225208-17-019019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817019019/doc4.xml","form_type":"4"}},{"id":4326231,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-05-11T11:46:13.000Z","date":"2014-12-17","kind":"sale","acquired":false,"shares":2741,"price":168.5068,"value":461877.1388,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price for price increments ranging from $167.82 to $168.68. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This transaction is being reported late and the amount in this column reflects the ownership immediately following this transaction.  Subsequent Form 4s overstated the reporting person's direct ownership by 2,741 shares."}],"balance_after":21995.5474,"source":{"system":"sec-edgar","filing":"0001225208-17-009475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817009475/doc4.xml","form_type":"4"}},{"id":4447793,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:41.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":2788,"price":240.5135,"value":670551.638,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for price increments ranging from $240.33 to $240.85. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":19530.1409,"source":{"system":"sec-edgar","filing":"0001225208-17-003412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003412/doc4.xml","form_type":"4"}},{"id":4447792,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:41.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":1897,"price":240.47,"value":456171.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program."}],"balance_after":22318.1409,"source":{"system":"sec-edgar","filing":"0001225208-17-003412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003412/doc4.xml","form_type":"4"}},{"id":4447791,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:41.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":447,"price":240.47,"value":107490.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":24684.1409,"source":{"system":"sec-edgar","filing":"0001225208-17-003412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003412/doc4.xml","form_type":"4"}},{"id":4453252,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-14T15:20:58.000Z","date":"2017-02-13","kind":"sale","acquired":false,"shares":469,"price":240.0721,"value":112593.8149,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for price increments ranging from $240.05 to $240.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":24662.1409,"source":{"system":"sec-edgar","filing":"0001225208-17-003182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003182/doc4.xml","form_type":"4"}},{"id":4453251,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-14T15:20:58.000Z","date":"2017-02-10","kind":"tax_withholding","acquired":false,"shares":417,"price":239.925,"value":100048.725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 0.0583 shares acquired under the Company's Dividend Reinvestment Plan from November 5, 2016 to February 3, 2017."}],"balance_after":25131.1409,"source":{"system":"sec-edgar","filing":"0001225208-17-003182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003182/doc4.xml","form_type":"4"}},{"id":4459038,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:35.000Z","date":"2017-02-09","kind":"sale","acquired":false,"shares":5816,"price":239.5782,"value":1393386.8112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sales price for price increments ranging from $239.49 to $239.83. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":25548.0826,"source":{"system":"sec-edgar","filing":"0001225208-17-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002837/doc4.xml","form_type":"4"}},{"id":4459037,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:35.000Z","date":"2017-02-08","kind":"tax_withholding","acquired":false,"shares":4004,"price":236.68,"value":947666.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":31364.0826,"source":{"system":"sec-edgar","filing":"0001225208-17-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002837/doc4.xml","form_type":"4"}},{"id":4459036,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:35.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":703,"price":164.843,"value":115884.629,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program."}],"balance_after":35368.0826,"source":{"system":"sec-edgar","filing":"0001225208-17-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002837/doc4.xml","form_type":"4"}},{"id":4459035,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:35.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":1641,"price":235.49,"value":386439.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program."}],"balance_after":34665.0826,"source":{"system":"sec-edgar","filing":"0001225208-17-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002837/doc4.xml","form_type":"4"}},{"id":4459034,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:35.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":3194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019."}],"balance_after":33024.0826,"source":{"system":"sec-edgar","filing":"0001225208-17-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002837/doc4.xml","form_type":"4"}},{"id":4459033,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:35.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":8223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from November 8, 2016 to February 6, 2017."}],"balance_after":29830.0826,"source":{"system":"sec-edgar","filing":"0001225208-17-002837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002837/doc4.xml","form_type":"4"}},{"id":4520133,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-12-16T15:35:38.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":11544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest in four equal annual installments beginning on December 14, 2017."}],"balance_after":11544,"derivative":{"exercise_price":219.555,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":11544},"source":{"system":"sec-edgar","filing":"0001225208-16-043394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043394/doc4.xml","form_type":"4"}},{"id":4525160,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"exercise","acquired":false,"shares":4663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Options fully vested and are currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":97.685,"expiration_date":"2022-12-12","underlying":"Common Stock","underlying_shares":4663},"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525159,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"exercise","acquired":false,"shares":4161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Of this option grant 4,161 options vested on December 11, 2016 and the remaining options vest on December 11, 2017."}],"balance_after":4161,"derivative":{"exercise_price":136.37,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":4161},"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525158,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"exercise","acquired":false,"shares":3767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Of this option grant 3,767 options vested on December 10, 2016 and the remaining options vest in two annual installments beginning on December 10, 2017."}],"balance_after":7535,"derivative":{"exercise_price":168.865,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":3767},"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525157,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-09","kind":"exercise","acquired":false,"shares":3292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Of this option grant 3,292 options vested on December 9, 2016 and the remaining options vest in three annual installments beginning on December 9, 2017."}],"balance_after":9879,"derivative":{"exercise_price":186.425,"expiration_date":"2025-12-09","underlying":"Common Stock","underlying_shares":3292},"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525156,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":5621,"price":219.6286,"value":1234532.3606,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sales price for price increments ranging from $219.18 to $220.17. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":21607.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525155,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":4167,"price":216.9804,"value":904157.3268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price for price increments ranging from $216.62 to $217.23. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":27228.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525154,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":1977,"price":220.377,"value":435685.329,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for price increments ranging from $220.18 to $220.78. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":31395.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525153,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":826,"price":218.8347,"value":180757.4622,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for price increments ranging from $218.17 to $219.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":33372.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525152,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"exercise","acquired":true,"shares":3767,"price":168.865,"value":636114.455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":34198.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525151,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"exercise","acquired":true,"shares":4161,"price":136.37,"value":567435.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":30431.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525150,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-12","kind":"exercise","acquired":true,"shares":4663,"price":97.685,"value":455505.155,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":26270.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525149,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-09","kind":"sale","acquired":false,"shares":3292,"price":215,"value":707780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":21607.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4525148,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-12-13T18:51:06.000Z","date":"2016-12-09","kind":"exercise","acquired":true,"shares":3292,"price":186.425,"value":613711.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 0.0632 shares acquired under the Company's Dividend Reinvestment Plan from July 30, 2016 to November 4, 2016.  Includes 0.001 shares acquired under the Company's Employee Stock Purchase Plan from August 2, 2016 to November 7, 2016."}],"balance_after":24899.0816,"source":{"system":"sec-edgar","filing":"0001225208-16-043118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043118/doc4.xml","form_type":"4"}},{"id":4609059,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-09-08T09:43:50.000Z","date":"2016-09-06","kind":"exercise","acquired":false,"shares":4161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Of this option grant 4,161 options vested on December 11, 2015 and the remaining options vest in two annual installments beginning on December 11, 2016."}],"balance_after":8322,"derivative":{"exercise_price":136.37,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":4161},"source":{"system":"sec-edgar","filing":"0001225208-16-039042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816039042/doc4.xml","form_type":"4"}},{"id":4609058,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Option (Right to Buy)","published_at":"2016-09-08T09:43:50.000Z","date":"2016-09-06","kind":"exercise","acquired":false,"shares":3767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Of this option grant 3,767 options vested on December 10, 2015 and the remaining options vest in three annual installments beginning on December 10, 2016."}],"balance_after":11302,"derivative":{"exercise_price":168.865,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":3767},"source":{"system":"sec-edgar","filing":"0001225208-16-039042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816039042/doc4.xml","form_type":"4"}},{"id":4609057,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-09-08T09:43:50.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":6667,"price":220.9526,"value":1473090.9842,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for price increments ranging from $220.42 to $221.39. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":21607.0174,"source":{"system":"sec-edgar","filing":"0001225208-16-039042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816039042/doc4.xml","form_type":"4"}},{"id":4609056,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-09-08T09:43:50.000Z","date":"2016-09-06","kind":"sale","acquired":false,"shares":1261,"price":221.644,"value":279493.084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for price increments ranging from $221.46 to $222.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":28274.0174,"source":{"system":"sec-edgar","filing":"0001225208-16-039042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816039042/doc4.xml","form_type":"4"}},{"id":4609055,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-09-08T09:43:50.000Z","date":"2016-09-06","kind":"exercise","acquired":true,"shares":3767,"price":168.865,"value":636114.455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":29535.0174,"source":{"system":"sec-edgar","filing":"0001225208-16-039042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816039042/doc4.xml","form_type":"4"}},{"id":4609054,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":27392,"kind":"person","name":"DeFord John A","position":1,"cik":"0001403373","reported_name":"DeFord John A","relationship":{"officer":true,"officer_title":"Sr. VP Sci Tech and Clin Afrs"}}],"security":"Common Stock","published_at":"2016-09-08T09:43:50.000Z","date":"2016-09-06","kind":"exercise","acquired":true,"shares":4161,"price":136.37,"value":567435.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 0.1202 shares acquired under the Company's Dividend Reinvestment Plan from February 6, 2016 to July 29, 2016.  Includes 0.002 shares acquired under the Company's Employee Stock Purchase Plan from February 6, 2016 to August 1, 2016."}],"balance_after":25768.0174,"source":{"system":"sec-edgar","filing":"0001225208-16-039042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816039042/doc4.xml","form_type":"4"}}]}